Active Shortage

OTIXAL

MEDEXUS PHARMACEUTICALS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of OTIXAL in Canada?

Yes. OTIXAL 0.3% 0.025% has an active shortage reported to Health Canada (last updated April 13, 2026).

Why is OTIXAL not available?

The reason the manufacturer reported: Shortage of an active ingredient.

When will OTIXAL be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength0.3% 0.025%

Last updated2026-04-13

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02459655

Strength

0.3% 0.025%

Dosage Form

SOLUTION

Route

OTIC

Active Ingredient

CIPROFLOXACIN FLUOCINOLONE ACETONIDE

Tier

Unrated

Last Updated

2026-04-13

Reason for Shortage

Shortage of an active ingredient.

Source

View original report on healthproductshortages.ca ↗

Other Products from MEDEXUS PHARMACEUTICALS INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

CUVPOSA

1MG · DIN 02469332

GLEOLAN

1.5G · DIN 02504928

METOJECT

7.5MG · DIN 02320029

METOJECT SUBCUTANEOUS

12.5MG · DIN 02454750

METOJECT SUBCUTANEOUS

10MG · DIN 02454831

METOJECT SUBCUTANEOUS

15MG · DIN 02454858